MB
Mitchell Brasher
Sales
Gerresheimer
About me
Primary Company Activity
Pharmaceutical Company (innovator finished products)
Department
Engineering
Position
Other
Purchasing Responsibility
I have no purchasing responsibility
Attendee Access Type
In-Person & Online
Registration Type
exhibitor-rep
Offering:
Offering: Markets Active in
United States of America
Interested:
Interested in: Business Activity
BiopharmaceuticalLaboratory, Analytical, Biotechnology EquipmentLaboratory ServicesMedical DevicesPharmaceutical Company (innovator finished products)Technology
Interested in: Company/Product Certifications
None
Interested in: Products or Services
Biopharmaceuticals
Geographical areas you plan to expand to:
None
Interested in: Biopharmaceuticals
Other
Interested in: Pharmaceutical products / ATC coding
Not Interested in Pharmaceutical products / ATC coding
Contact details
Is member of
Gerresheimer AG
Exhibitors
Gerresheimer AG
Exhibitors
Gerresheimer & Bormiloi Pharma
Exhibitors
Gerresheimer
Exhibitors
Gerresheimer
Exhibitorsis attending
The Lasting Impact of COVID-19 on Drug Development
The Real Cost of Bringing Manufacturing Home
KENNETH DREW · FLAMMA
Wayne Weiner · Pharmatech Solutions LLC
Fujifilm Activities for Liposome and Lipid Nanoparticle Development in the Pharmaceutical Industry
Tuesday, October 8, 2024 12:15 PM to 12:40 PM
Hall 5 - 5B49
Gx Elite RTF® Glass and Polymer Syringes – First Choice for Demanding Biologics
Tuesday, October 8, 2024 12:45 PM to 1:10 PM
Hall 20 - 20C33
Philip Bortner · Gerresheimer
EXVIS-Dr. Christian Redeker · EXVIS-Gerresheimer
Opening Keynote - Navigating the Shift Toward Ready-To-Use Technology
Tuesday, October 8, 2024 8:30 AM to 8:45 AM
Hall 20 - 20C33